Skip to content

Clinical trials

Phase 2 Genetic Diseases, Inborn trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Phase: Phase 2 Country / region: United States Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20061
20072
20092
20101
20112
20122
20141
20184
20191
20201
20214
20222
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated7
Enrolling by invitation3
Recruiting2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated4
National Cancer Institute (NCI)3
Novartis Pharmaceuticals3
QED Therapeutics, a BridgeBio company3
National Center for Research Resources (NCRR)2
National Institutes of Health Clinical Center (CC)2
Alexion Pharmaceuticals, Inc.1
Avidity Biosciences, Inc.1
BioMarin Pharmaceutical1
Boston University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn40
Musculoskeletal Diseases7
Rare Diseases7
Anemia, Sickle Cell5
Bone Diseases5
Cystic Fibrosis5
Infant, Newborn, Diseases5
Neoplasms5
Osteochondrodysplasias5
Achondroplasia4

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.